Companies/Nanalysis Scientific Corp.

Company profile

Nanalysis Scientific Corp.

OTC: NSCIF · Healthcare · Medical - Specialties

Canadian filerHQ Calgary, ABReports USD

#504 of 1,394 Healthcare companies by revenue30th-percentile growth

EA Score

58C

FH 61DQ —GM 49SS 58

v0.1 · 45/100 weight · provisional

↑ workforce scale, return on assets · ↓ listing tenure, revenue growth (YoY)

Methodology →

Revenue TTM

$29.1M

Rev growth YoY (TTM)

-9.9%

Net income (FY)

-$4.0M

Employees

15,299

Market cap

$10.3M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$28.7M40.1M CAD2025

Net income-$4.0M-5.7M CAD2025

Operating income-$2.7M-3.8M CAD2025

Total assets$28.0M38.4M CAD2025

Liabilities$18.2M25.0M CAD2025

Equity$9.8M13.4M CAD2025

Revenue trend

FY2018 – FY2025 · USD

$6.5M

FY18

$6.3M

FY19

$5.9M

FY20

$12.8M

FY21

$19.1M

FY22

$21.1M

FY23

$33.2M

FY24

$28.7M

FY25

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Nanalysis Scientific Corp. booked $28.7M in FY2025 revenue, contracting 14% year over year — slower than 70% of Healthcare companies we track, at a -14.1% net margin.

Peers · Healthcare

Red Light Holland Corp.——Rapid Dose Therapeutics Corp.38D Avem Health Partners, Inc.——Cocrystal Pharma, Inc.31D

Key facts

CEOSean Krakiwsky

SectorHealthcare

IndustryMedical - Specialties

HeadquartersCalgary, AB

ExchangeOTC: NSCIF

Employees15,299

IPO date2020-04-16

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.